Annual report pursuant to Section 13 and 15(d)

NOTES PAYABLE (Details Narrative)

NOTES PAYABLE (Details Narrative) - USD ($)			1 Months Ended			12 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Mar. 06, 2024	Jul. 28, 2020	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2021	Dec. 31, 2023	Dec. 31, 2022
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount						$ 2,954,390	$ 2,954,390
Interest Expense, Debt						3,810,000	3,097,000
Lenders [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount						2,954,000
K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt issuance cost		$ 1,244,000
Insurance Policy [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Prepaid Expense, Current						$ 345,667	418,750
Loan Agreement [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Notes payable			$ 373,320	$ 452,250	$ 984,375
Debt Instrument, Periodic Payment			$ 38,741	$ 51,387	$ 111,041
Monthly loan payments term			ten-month period	nine-month period	nine-month period
Debt Instrument, Interest Rate, Stated Percentage			8.15%	5.40%	3.64%
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						13.75%
Secured debt						$ 17,893,738
Debt Instrument, Description		The loan matures on August 1, 2024 and the Company is obligated to make interest only payments for the first 24 months and then interest and equal principal payments for the next 24 months commencing on September 1, 2022.
Debt Instrument, Maturity Date		Aug. 01, 2024
Debt Conversion, Converted Instrument, Amount	$ 1,125,000					$ 875,000	$ 5,000,000
Conversion price per share	$ 7.875					$ 4.5	$ 282
Warrants to purchase shares of common stock, exercised	142,857	2,873				194,444
Exercise price of warrants		$ 208.8
Proceeds from Warrant Exercises		$ 472,000
Proceeds from prepayment and default features		546,000
Final payment		1,590,000				$ 1,590,000
Increase in fair value of conversion option							$ 573,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-based Payment Arrangement, Tranche One [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt		$ 20,000,000
Event of Default - Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Interest Rate, Stated Percentage						5.00%
Debt Instrument, Maturity Date						Aug. 01, 2024
Amended loan agreement \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Description		The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. The Amended Loan and Security Agreement defers the commencement of principal repayments by a one-year period from September 1, 2022 to September 1, 2023 and if the Company raises at least $30 million in net proceeds through capital raising transactions, the commencement of principal repayments will be deferred by an additional six months to March 1, 2024. Interest accrues at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.
Debt issuance cost		$ 119,000
Debt 1 [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Conversion, Converted Instrument, Amount							2,000,000
Debt 1a [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Conversion, Converted Instrument, Amount						$ 4,125,000	$ 875,000
Debt 1a [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Maximum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Conversion price per share							$ 4.5
Debt 1a [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Minimum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Conversion price per share							$ 282
Debt 1b [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Conversion, Converted Instrument, Amount							$ 1,125,000
Debt 1b [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Maximum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Conversion price per share							$ 7.875
Debt 1b [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Minimum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Conversion price per share							$ 282
Debt 2 [Member] \| Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Conversion, Converted Instrument, Amount							$ 3,000,000
Conversion price per share							$ 282